Calls
1
u/Papercut-34
Reddit r/biotech_stocks
Win Rate
100.0%
return
+1.0%
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Short
Sep 13
$11.56
+1.0%
The author believes the underlying clinical data for GPS and SLS009 is strong and expects the stock to recover following the final REGAL trial results. The primary risk identified is the company's lack of a clear commercialization strategy post-approval.
Pharma & Biotech
Showing 1 of 1 calls · sorted by mentions
Choose a mentions count to open ticker posts.
u/Papercut-34 has 1 trade ideas tracked on Buzzberg across 1 tickers since September 2026. Most covered: SLS.
Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology
